Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
galactooligosaccharides
- Development stage
- Unknown
- Lead developer
- Yakult Pharmaceutical Industry
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Oligomate is a brand of galactooligosaccharides (GOS) developed by Yakult Pharmaceutical Industry. It is a non-digestible prebiotic functional food ingredient derived from lactose through enzymatic conversion using beta-galactosidase. As a prebiotic, Oligomate passes through the upper gastrointestinal tract undigested and reaches the colon, where it serves as a selective carbon source for beneficial bacteria, particularly *Bifidobacterium* species. The fermentation of GOS by these bacteria produces short-chain fatty acids (SCFAs), which lower intestinal pH, inhibit the growth of potential pathogens, and support overall digestive health and immune function. Oligomate is widely used as a functional ingredient in various food products, including dairy, infant formula, and dietary supplements, and is recognized in Japan as a Food for Specified Health Uses (FOSHU).
- Brand names
- OligomateOLIGOMATE 55OLIGOMATE55OLIGOMATE-55OLIGOMATE 55NOLIGOMATE55NOLIGOMATE-55NOLIGOMATE 55POLIGOMATE55POLIGOMATE-55P
- Other names
- GOSgalactooligosaccharides
Beyond the preview
Go deeper on galactooligosaccharides.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on galactooligosaccharides.